Why IMU is a multi multi bagger, page-24369

Poster endorsement is no way to treat an investment.

Remember, Relyviro got approved by the FDA and sold in the market for well over 12 months before it just got pulled due to showing a lack of efficacy.

Stop putting your trust in CEO’s, paid institutions, and companies and start focusing on the science, by science I mean the quality of the data, patient outcome, in well designed trials. Not single digit CRs or murky combo treatments.

It’s unfortunate many are holding on here but at some point you’ll need to cut your losses or deal with the fact that it might be another 4-5yrs before you see a return on your funds all going well. With the amount of opportunity on the ASX and other biotechs with solid science doing well, I cannot understand why IMU is the pick.